✦ LIBER ✦

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

✍ Scribed by Malkasian, George D.; Knapp, Robert C.; Lavin, Philip T.; Zurawski, Vincent R.; Podratz, Karl C.; Stanhope, C. Robert; Mortel, Rodrique; Berek, Jonathan S.; Bast, Robert C.; Ritts, Roy E.

Book ID: 122115714
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 628 KB
Volume: 159
Category: Article
ISSN: 1097-6868
DOI: 10.1016/S0002-9378(88)80081-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative evaluation of serum CA 125

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease

✍ GD Malkasian Jr; RC Knapp; PT Lavin; VR Zurawski Jr; KC Podratz; CR Stanhope; R 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Preoperative Evaluation of D-Dimer and C

Preoperative Evaluation of D-Dimer and CA 125 Levels in Differentiating Benign from Malignant Ovarian Masses

✍ Angiolo Gadducci; Ugo Baicchi; Roberto Marrai; Marco Ferdeghini; Romano Bianchi; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 285 KB

The value of preoperative serum CA 125 l

The value of preoperative serum CA 125 levels in patients with a pelvic mass

✍ Patsner, Bruce; Mann, William J. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Significance of CA 125 serum level in di

Significance of CA 125 serum level in discrimination between benign and malignant masses in the pelvis

✍ Miodrag Milojkovic; Zlatko Hrgovic; Igor Hrgovic; Walter Jonat; Nicolai Maass; D 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 183 KB

Comparison of three malignancy risk indi

Comparison of three malignancy risk indices and CA-125 in the preoperative evaluation of patients with pelvic masses

✍ Zinatossadat Bouzari; Shahla Yazdani; Mahmoud Haji Ahmadi; Shahnaz Barat; Ziba S 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 132 KB

Lipoprotein(a) and CA125 levels in the p

Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease

✍ Annette C. Kuesel; Thérèse Kroft; Michel Préfontaine; Ian C. P. Smith 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 690 KB

## Abstract Elevated plasma levels of apolipoprotein (a) have been reported earlier in cancer patients. In order to investigate the potential of apolipoprotein(a) as an ovarian tumour marker, plasma apolipoprotein(a) and CA125 levels were measured in healthy women and women with benign or malignant